Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

5.05
-0.4200-7.68%
Volume:106.16K
Turnover:561.12K
Market Cap:253.86M
PE:-2.88
High:5.64
Open:5.54
Low:5.03
Close:5.47
Loading ...

Press Release: Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Dow Jones
·
25 Mar

Aura Biosciences Down Over 7%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Dow Jones
·
25 Mar

Promising Phase 1 Results for Aura Biosciences’ Bel-sar in Bladder Cancer Boost Buy Rating

TIPRANKS
·
25 Mar

Buy Recommendation for Aura Biosciences: Promising Phase 1 Trial Results and Dual Mechanism of Action in Bladder Cancer Treatment

TIPRANKS
·
24 Mar

Aura Biosciences Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Mar

Aura Biosciences Reports 'Robust' Anti-Tumor Immune Response From Phase 1 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer

MT Newswires Live
·
24 Mar

Positive Data From Phase 1 Trial of Bel-SAR in Patients With Non-Muscle-Invasive Bladder Cancer (Nmibc) Presented at the 40TH Annual European Association of Urology Congress

THOMSON REUTERS
·
24 Mar

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

GlobeNewswire
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Promising Developments in Aura Biosciences Inc’s Clinical Trials Lead to Buy Rating

TIPRANKS
·
04 Mar

Buy Rating for Aura Biosciences Driven by Promising Bel-sar Developments and Market Potential

TIPRANKS
·
03 Mar

Aura Biosciences Announces Additional Data From Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to Be Presented as a Late-Breaking Abstract at the 40TH Annual European Association of Urology Congress

THOMSON REUTERS
·
03 Mar

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

GlobeNewswire
·
03 Mar

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Aura Announces Change in Shareholder Structure

TIPRANKS
·
18 Feb

Aura Announces Change in Interested Parties

TIPRANKS
·
18 Feb

Companies Like Aura Biosciences (NASDAQ:AURA) Are In A Position To Invest In Growth

Simply Wall St.
·
11 Feb

Aura Energy Limited (AURA) Receives a Buy from Petra Capital

TIPRANKS
·
30 Jan

We Think Aura Biosciences (NASDAQ:AURA) Can Afford To Drive Business Growth

Simply Wall St.
·
11 Jan

AdEx Launches AI Powered Onchain Activity Analyzer ‘AURA’ to Enhance Web3 Experiences

CoinMarketCap
·
24 Dec 2024